semaglutide and psoriasis GLP-1RAs found to have a protective effect in psoriasis

Semaglutide therapy decreases epicardial fat inflammation and improves psoriasis severity in patients affected by abdominal obesity and type-2 diabetes in: Endocrinology, Diabetes & Metabolism Case Reports Volume 2023 Issue 3 (2023)

23.40

★★★★☆4.8 (126)

GLP1s for PsO and HS -

24.61

★★★★★4.9 (98)

Most dermatologists and rheumatologists agree that GLP-1 receptor agonists (GLP-1 RAs), such as liraglutide, semaglutide, and tirzepatide, powerful antidiabetes and weight-loss drugs, have the potential to help some patients with psoriasis and

21.48

★★★★★5.0 (157)

obesity #psoriasis #glp1 #realworldevidence #patientcentredcare #yazenhealth #yazen

23.24

★★★★★4.7 (84)

Frontiers

26.07

★★★★★4.9 (203)

GLP-1s aren't just changing weight management, they're showing up in the dermatology clinic. Various cutaneous effects and evolving inflammatory skin disease patterns are all part of the conversation. Swipe to learn the

23.44

★★★★★5.0 (176)

Psoriasis isn't just a skin condition—it's linked to higher risks of heart disease, depression, and substance use. Early research suggests that weight-loss drugs called GLP-1 receptor agonists (like Ozempic, Wegovy, and Zepbound)

27.98

★★★★★4.8 (132)